Article / Bristol-Myers Squibb Pharma Co



Singapore Patents – High Courts disallows Correction to Patent Register with regard to Error in Priority Application Number due to Undue Delay and there being no Exceptional Grounds to rely upon for Bristol-Myers in seeking correction – Norvatis (Singapor

Intellectual Property News In a decision rendered by Singapore’s High Court on 20 December 2017, the High Court allowed an application by Novartis (Singapore) Pte Ltd (commenced under Section 44(1)... Read more